Literature DB >> 20534328

Alterations in lipid profile of autistic boys: a case control study.

Eun-Kyung Kim1, Yasmin H Neggers, Cheung-Soo Shin, Eunkyeong Kim, Eun Mi Kim.   

Abstract

We hypothesize that autism is associated with alterations in the plasma lipid profile and that some lipid fractions in autistic boys may be significantly different than those of healthy boys. A matched case control study was conducted with 29 autistic boys (mean age, 10.1 +/- 1.3 years) recruited from a school for disabled children and 29 comparable healthy boys from a neighboring elementary school in South Korea. Fasting plasma total cholesterol (T-Chol), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), the LDL/HDL ratio, and 1-day food intakes were measured. Multiple regression analyses were performed to assess the association between autism and various lipid fractions. The mean TG level (102.4 +/- 52.4 vs 70.6 +/- 36.3; P = .01) was significantly higher, whereas the mean HDL-C level (48.8 +/- 11.9 vs 60.5 +/- 10.9 mg/dL; P = .003) was significantly lower in cases as compared to controls. There was no significant difference in T-Chol and LDL-C levels between cases and controls. The LDL/HDL ratio was significantly higher in cases as compared to controls. Multiple regression analyses indicated that autism was significantly associated with plasma TG (beta = 31.7 +/- 11.9; P = .01), HDL (beta = -11.6 +/- 2.1; P = .0003), and the LDL/HDL ratio (beta = 0.40 +/- 0.18; P = .04). There was a significant interaction between autism and TG level in relation to plasma HDL level (P = .02). Fifty-three percent of variation in the plasma HDL was explained by autism, plasma TG, LDL/HDL ratio, and the interaction between autism and plasma TG level. These results indicate the presence of dyslipidemia in boys with autism and suggest a possibility that dyslipidemia might be a marker of association between lipid metabolism and autism. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534328     DOI: 10.1016/j.nutres.2010.04.002

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  15 in total

1.  A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder.

Authors:  Ryan W Y Lee; Michael J Corley; Alina Pang; Gaye Arakaki; Lisa Abbott; Michael Nishimoto; Rob Miyamoto; Erica Lee; Susan Yamamoto; Alika K Maunakea; Annette Lum-Jones; Miki Wong
Journal:  Physiol Behav       Date:  2018-02-05

2.  Cholesterol, GM1, and autism.

Authors:  Cara-Lynne Schengrund; Fatima Ali-Rahmani; Jeanette C Ramer
Journal:  Neurochem Res       Date:  2012-01-18       Impact factor: 3.996

3.  Multi-omics data reveals the disturbance of glycerophospholipid metabolism caused by disordered gut microbiota in depressed mice.

Authors:  Tian Tian; Qiang Mao; Jing Xie; Ying Wang; Wei-Hua Shao; Qi Zhong; Jian-Jun Chen
Journal:  J Adv Res       Date:  2021-10-13       Impact factor: 12.822

4.  A multidimensional precision medicine approach identifies an autism subtype characterized by dyslipidemia.

Authors:  Yuan Luo; Alal Eran; Nathan Palmer; Paul Avillach; Ami Levy-Moonshine; Peter Szolovits; Isaac S Kohane
Journal:  Nat Med       Date:  2020-08-10       Impact factor: 53.440

5.  Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice.

Authors:  Giuseppe D'Agostino; Claudia Cristiano; David J Lyons; Rita Citraro; Emilio Russo; Carmen Avagliano; Roberto Russo; Giuseppina Mattace Raso; Rosaria Meli; Giovambattista De Sarro; Lora K Heisler; Antonio Calignano
Journal:  Mol Metab       Date:  2015-05-02       Impact factor: 7.422

Review 6.  Potential biomarkers in psychiatry: focus on the cholesterol system.

Authors:  Alisa G Woods; Izabela Sokolowska; Regina Taurines; Manfred Gerlach; Edward Dudley; Johannes Thome; Costel C Darie
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

Review 7.  An "Omic" Overview of Fragile X Syndrome.

Authors:  Olivier Dionne; François Corbin
Journal:  Biology (Basel)       Date:  2021-05-13

8.  Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.

Authors:  George Anderson; Michael Maes
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

Review 9.  Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Clin Med Insights Pediatr       Date:  2016-06-15

10.  VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction.

Authors:  Noriyoshi Usui; Keiko Iwata; Taishi Miyachi; Shu Takagai; Keisuke Wakusawa; Takahiro Nara; Kenji J Tsuchiya; Kaori Matsumoto; Daisuke Kurita; Yosuke Kameno; Tomoyasu Wakuda; Kiyokazu Takebayashi; Yasuhide Iwata; Toru Fujioka; Takaharu Hirai; Manabu Toyoshima; Tetsuo Ohnishi; Tomoko Toyota; Motoko Maekawa; Takeo Yoshikawa; Masato Maekawa; Kazuhiko Nakamura; Masatsugu Tsujii; Toshiro Sugiyama; Norio Mori; Hideo Matsuzaki
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.